Chikujee Technology
THE Aayush personalized Health care PLATFORM
Our platform based strategy of
focused diversification helps us to
capitalize on this changing
healthcare environment while
balancing risk. Chikujee has leading
businesses in science-based, fast
growing segments of healthcare.
Chikujee aims to change the
practice of medicine, and innovation
at Chikujee not only means
developing effective, targeted
medicines quickly, but also ensuring
that these medicines get to the
patients who need them at an
affordable price.
Chikujee strives to ensure that
patients can benefit from new and
effective drugs as quickly as
possible by:
-
Prioritizing our personalized
medicine development efforts
based on sound science and
market need
- Leveraging
our core research and
development capabilities across
all divisions to continue
building our pipeline of
innovative pharmaceuticals;
affordable, high-quality branded
generics; diagnostics and
reporters of therapeutic
efficacy; and consumer health
products
- Shifting
to a more integrated approach,
working together with physicians
and our customers to optimize
clinical outcomes
-
Identifying biomarkers to
develop high-quality companion
diagnostics in support of our
medicines across all therapeutic
areas
- Carefully
designing clinical trials to
generate data that helps
governments measure the economic
benefits of new medicines
- Partnering
with appropriate groups to
advance common goals of
commercializing innovative
healthcare solutions
The success of this strategy is
evident in our long-established
track record of research
productivity. During the last three
years, Chikujee has completed proof
of concept studies in each major
component in the drug development
life cycle in three major healthcare
domains (Cardiovascular, Oncology
and CNS) - in vitro and in vivo
diagnostics, targeted therapeutics,
and reporters of therapeutic
efficacy.
